SOLV Q1 2026 Earnings EPS Beat by 73 Amid Operational Efficiency GRI Q1 2026 Earnings WiderThanExpected Loss Deepens as PreRevenue Biotech Faces Headwinds Post Holdings Q1 2026 Earnings Strong EPS Beat Masks Mixed Underlying Performance CLLS Q1 2026 Earnings Narrowed Loss Surprises Amid Clinical Focus HIG Q1 2026 Earnings EPS Misses Estimates Amid Elevated Catastrophe Losses HOVNP Q1 2026 Earnings Preferred Stock Reports NarrowerthanExpected Loss on Strong Operating Trends